|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.230 USD | -3.75% |
|
-4.65% | -12.10% |
| 17/07 | Moderna advances its cancer therapy assessment, but the stock slides |  |
| 01/06 | Immatics N.V. Announces Updated Clinical Data For IMA203CD8, IMA401, And Anzu-Cel PRAME Cell Therapies | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.75% | -4.65% | -5.62% | -17.37% | -12.10% | +53.83% | -24.03% | -23.02% | - | 1.31B | |
| +0.21% | -1.34% | -2.61% | +4.99% | +5.13% | +53.17% | +60.65% | +185.13% | +5,696.92% | 53.83B | |
| +5.37% | +0.75% | +20.93% | +24.98% | +37.05% | +50.39% | +83.03% | -25.99% | - | 52.1B | |
| -1.20% | -7.43% | +11.71% | -25.93% | -38.51% | +4.35% | +406.96% | +316.42% | +888.18% | 23.48B | |
| +0.74% | +0.73% | +1.40% | -10.45% | -3.19% | -16.23% | -15.55% | -62.02% | - | 23.13B | |
| +3.46% | +0.79% | +24.14% | +7.11% | +21.69% | +34.01% | -4.47% | -72.59% | - | 19.36B | |
| -1.18% | -1.15% | +12.86% | +2.38% | -8.88% | +30.12% | -32.02% | -32.10% | +59.22% | 17.56B | |
| -1.67% | -8.56% | +22.96% | +99.60% | +177.32% | +163.95% | +284.69% | +1,543.66% | +625.02% | 15.2B | |
| +3.62% | -2.42% | +21.21% | -3.08% | +28.51% | +29.70% | +663.64% | - | - | 14.83B | |
| -0.70% | -1.72% | +6.97% | +23.70% | +26.69% | +24.87% | +184.19% | +240.67% | +563.44% | 14.06B | |
| -3.21% | -0.19% | +5.92% | +0.69% | -8.01% | +60.32% | +147.14% | +482.97% | - | 12.76B | |
| -1.33% | -6.79% | +0.42% | +18.59% | +24.50% | +112.49% | +135.31% | +193.00% | +728.38% | 10.89B | |
| -2.24% | -11.48% | -1.82% | -46.32% | -22.81% | -48.47% | +539.81% | +95.94% | +87.50% | 10.72B | |
| -3.57% | -6.22% | -12.43% | +3.08% | +7.92% | +327.51% | +107.26% | +9.31% | +1,179.46% | 10.47B | |
| +5.66% | -4.01% | +6.62% | -38.18% | -17.39% | -33.65% | +160.03% | +62.91% | - | 10.38B | |
| +0.02% | +0.05% | +0.43% | +15.19% | +23.23% | +48.63% | +178.44% | - | - | 9.83B | |
| +0.01% | +0.35% | +133.82% | +104.56% | +80.17% | +169.59% | +327.69% | +330.99% | - | 8.84B | |
| -2.89% | -0.42% | +10.18% | +33.31% | +197.10% | +497.48% | +508.31% | -42.49% | -16.09% | 8.81B | |
| +0.74% | -.--% | -.--% | -.--% | -.--% | -.--% | +54.45% | +110.19% | - | 8.19B | |
| -1.25% | -4.66% | +7.89% | -10.99% | +20.29% | +53.27% | +19.35% | +142.57% | - | 8.12B | |
| Average | -0.16% | -2.35% | +13.25% | +9.29% | +26.94% | +80.77% | +189.24% | +191.98% | +1,090.23% | 16.69B | |
| Weighted average by Cap. | +0.76% | -2.38% | +12.12% | +9.90% | +22.86% | +63.20% | +163.29% | +175.00% | +2,224.47% |
- Stock Market
- Stocks
- IMTX Stock
- Sector Immatics N.V.
Select your edition
All financial news and data tailored to specific country editions
